4 – Alzheimers

Complementary approaches to Alzheimer’s research were recognized as four scientists received the prestigious MetLife Foundation Awards for Medical Research in Alzheimer’s Disease in Washington, D.C.

Excerpt from:
MetLife Foundation Awards for Medical Research in Alzheimer’s ... continue reading

Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or loss of activities of daily living compared to patients who received placebo, ... continue reading